XBiotech (XBIT) Revenue (2020 - 2022)

XBiotech has reported Revenue for 3 years, with the latest figure at $1.7 million in Q3 2022.

• On a quarterly basis, Revenue fell 62.82% year-over-year to $1.7 million in Q3 2022; TTM through Sep 2023 was $1.7 million, a 79.54% decrease from a year earlier, with the FY2022 full-year figure at $4.0 million, down 78.2% from the prior year.
• Revenue was $1.7 million for Q3 2022 at XBiotech, up from $1.5 million in the prior quarter.
• The five-year high for Revenue was $15.5 million in Q2 2020, with the low at $500000.0 in Q1 2022.
• Average Revenue over 3 years is $6.0 million, with a median of $4.5 million recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Revenue decreased 14.59% in 2021, then tumbled 89.69% in 2022.
• Over 3 years, Revenue stood at $5.3 million in 2020, then retreated by 14.59% to $4.5 million in 2021, then slumped by 62.67% to $1.7 million in 2022.
• The last three Revenue figures came in at $1.7 million (Q3 2022), $1.5 million (Q2 2022), and $500000.0 (Q1 2022), per Business Quant data.